• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

疟原虫 PfPA28-20S 蛋白酶体复合物的结构及其对蛋白质稳态的影响。

The structure of the PA28-20S proteasome complex from Plasmodium falciparum and implications for proteostasis.

机构信息

Department of Biochemistry and Molecular Biology, Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Melbourne, Victoria, Australia.

Advanced Microscopy Facility, Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Melbourne, Victoria, Australia.

出版信息

Nat Microbiol. 2019 Nov;4(11):1990-2000. doi: 10.1038/s41564-019-0524-4. Epub 2019 Aug 5.

DOI:10.1038/s41564-019-0524-4
PMID:31384003
Abstract

The activity of the proteasome 20S catalytic core is regulated by protein complexes that bind to one or both ends. The PA28 regulator stimulates 20S proteasome peptidase activity in vitro, but its role in vivo remains unclear. Here, we show that genetic deletion of the PA28 regulator from Plasmodium falciparum (Pf) renders malaria parasites more sensitive to the antimalarial drug dihydroartemisinin, indicating that PA28 may play a role in protection against proteotoxic stress. The crystal structure of PfPA28 reveals a bell-shaped molecule with an inner pore that has a strong segregation of charges. Small-angle X-ray scattering shows that disordered loops, which are not resolved in the crystal structure, extend from the PfPA28 heptamer and surround the pore. Using single particle cryo-electron microscopy, we solved the structure of Pf20S in complex with one and two regulatory PfPA28 caps at resolutions of 3.9 and 3.8 Å, respectively. PfPA28 binds Pf20S asymmetrically, strongly engaging subunits on only one side of the core. PfPA28 undergoes rigid body motions relative to Pf20S. Molecular dynamics simulations support conformational flexibility and a leaky interface. We propose lateral transfer of short peptides through the dynamic interface as a mechanism facilitating the release of proteasome degradation products.

摘要

蛋白酶体 20S 催化核心的活性受到结合在其一端或两端的蛋白复合物的调节。PA28 调节因子在体外刺激 20S 蛋白酶体肽酶活性,但它在体内的作用尚不清楚。在这里,我们表明从恶性疟原虫(Pf)中遗传缺失 PA28 调节剂使疟原虫对青蒿素类药物二氢青蒿素更加敏感,表明 PA28 可能在抵御蛋白毒性应激中发挥作用。PfPA28 的晶体结构揭示了一个钟形分子,其内部孔具有强烈的电荷分离。小角度 X 射线散射表明,在晶体结构中未解析的无序环从 PfPA28 七聚体延伸,并环绕孔。使用单颗粒冷冻电镜,我们以 3.9 和 3.8 Å 的分辨率分别解决了 Pf20S 与一个和两个调节性 PfPA28 帽复合物的结构。PfPA28 不对称地结合 Pf20S,仅在核心的一侧强烈结合亚基。PfPA28 相对于 Pf20S 发生刚体运动。分子动力学模拟支持构象灵活性和泄漏接口。我们提出通过动态界面进行短肽的横向转移作为促进蛋白酶体降解产物释放的机制。

相似文献

1
The structure of the PA28-20S proteasome complex from Plasmodium falciparum and implications for proteostasis.疟原虫 PfPA28-20S 蛋白酶体复合物的结构及其对蛋白质稳态的影响。
Nat Microbiol. 2019 Nov;4(11):1990-2000. doi: 10.1038/s41564-019-0524-4. Epub 2019 Aug 5.
2
The cryo-EM structure of the Plasmodium falciparum 20S proteasome and its use in the fight against malaria.恶性疟原虫20S蛋白酶体的冷冻电镜结构及其在抗击疟疾中的应用。
FEBS J. 2016 Dec;283(23):4238-4243. doi: 10.1111/febs.13780. Epub 2016 Jul 2.
3
Design of proteasome inhibitors with oral efficacy in vivo against and selectivity over the human proteasome.设计具有体内抗 和对人蛋白酶体选择性的口服功效的蛋白酶体抑制剂。
Proc Natl Acad Sci U S A. 2021 Sep 28;118(39). doi: 10.1073/pnas.2107213118.
4
Spatial arrangement and functional role of α subunits of proteasome activator PA28 in hetero-oligomeric form.蛋白酶体激活剂 PA28α 亚基的异源寡聚体形式的空间排列和功能作用。
Biochem Biophys Res Commun. 2013 Mar 1;432(1):141-5. doi: 10.1016/j.bbrc.2013.01.071. Epub 2013 Jan 29.
5
High-resolution cryo-EM proteasome structures in drug development.高分辨率冷冻电镜蛋白酶体结构在药物研发中的应用。
Acta Crystallogr D Struct Biol. 2017 Jun 1;73(Pt 6):522-533. doi: 10.1107/S2059798317007021. Epub 2017 May 31.
6
Structure- and function-based design of Plasmodium-selective proteasome inhibitors.基于结构和功能的疟原虫选择性蛋白酶体抑制剂设计。
Nature. 2016 Feb 11;530(7589):233-6. doi: 10.1038/nature16936.
7
Interactions of PAN's C-termini with archaeal 20S proteasome and implications for the eukaryotic proteasome-ATPase interactions.PAN 的 C 末端与古菌 20S 蛋白酶体的相互作用及其对真核蛋白酶体-ATP 酶相互作用的影响。
EMBO J. 2010 Feb 3;29(3):692-702. doi: 10.1038/emboj.2009.382. Epub 2009 Dec 17.
8
Antimalarial proteasome inhibitor reveals collateral sensitivity from intersubunit interactions and fitness cost of resistance.抗疟蛋白酶体抑制剂揭示了亚基间相互作用的副作用敏感性和耐药性的适应代价。
Proc Natl Acad Sci U S A. 2018 Jul 17;115(29):E6863-E6870. doi: 10.1073/pnas.1806109115. Epub 2018 Jul 2.
9
Covalent Plasmodium falciparum-selective proteasome inhibitors exhibit a low propensity for generating resistance in vitro and synergize with multiple antimalarial agents.共价型疟原虫选择性蛋白酶体抑制剂在体外产生耐药性的倾向较低,并与多种抗疟药物具有协同作用。
PLoS Pathog. 2019 Jun 6;15(6):e1007722. doi: 10.1371/journal.ppat.1007722. eCollection 2019 Jun.
10
Improvement of Asparagine Ethylenediamines as Anti-malarial -Selective Proteasome Inhibitors.作为抗疟选择性蛋白酶体抑制剂的天冬酰胺乙二胺的改良。
J Med Chem. 2019 Jul 11;62(13):6137-6145. doi: 10.1021/acs.jmedchem.9b00363. Epub 2019 Jun 20.

引用本文的文献

1
Recombinant proteasome provides new avenues for anti-malarial drug development.重组蛋白酶体为抗疟疾药物研发提供了新途径。
bioRxiv. 2025 Aug 14:2025.08.13.670186. doi: 10.1101/2025.08.13.670186.
2
Not Just PA28γ: What We Know About the Role of PA28αβ in Carcinogenesis.不仅仅是PA28γ:我们对PA28αβ在致癌作用中的作用的了解。
Biomolecules. 2025 Jun 16;15(6):880. doi: 10.3390/biom15060880.
3
Evaluation of binding activities of a putative lipoprotein LIC_13355 of Leptospira spp.钩端螺旋体属假定脂蛋白LIC_13355结合活性的评估
FEBS Open Bio. 2025 Mar;15(3):447-461. doi: 10.1002/2211-5463.13942. Epub 2024 Dec 12.
4
Pharmacological and structural understanding of the Trypanosoma cruzi proteasome provides key insights for developing site-specific inhibitors.对克氏锥虫蛋白酶体的药理学和结构理解为开发位点特异性抑制剂提供了关键见解。
J Biol Chem. 2025 Jan;301(1):108049. doi: 10.1016/j.jbc.2024.108049. Epub 2024 Dec 9.
5
Ubiquitin-proteasome system in : a potential antimalarial target to overcome resistance - a systematic review.泛素-蛋白酶体系统:克服耐药性的潜在抗疟靶点——一项系统综述
Front Med (Lausanne). 2024 Oct 21;11:1441352. doi: 10.3389/fmed.2024.1441352. eCollection 2024.
6
Enhanced cell stress response and protein degradation capacity underlie artemisinin resistance in .青蒿素耐药性的基础是增强的细胞应激反应和蛋白质降解能力。
mSphere. 2024 Nov 21;9(11):e0037124. doi: 10.1128/msphere.00371-24. Epub 2024 Oct 22.
7
Structural elucidation of recombinant Trichomonas vaginalis 20S proteasome bound to covalent inhibitors.结构解析重组阴道毛滴虫 20S 蛋白酶体与共价抑制剂结合。
Nat Commun. 2024 Oct 4;15(1):8621. doi: 10.1038/s41467-024-53022-w.
8
Conformations of Bcs1L undergoing ATP hydrolysis suggest a concerted translocation mechanism for folded iron-sulfur protein substrate.Bcs1L 在进行 ATP 水解时的构象表明折叠的铁硫蛋白底物的协同易位机制。
Nat Commun. 2024 May 31;15(1):4655. doi: 10.1038/s41467-024-49029-y.
9
Selective targeting of Plasmodium falciparum Hsp90 disrupts the 26S proteasome.疟原虫 Hsp90 的选择性靶向破坏 26S 蛋白酶体。
Cell Chem Biol. 2024 Apr 18;31(4):729-742.e13. doi: 10.1016/j.chembiol.2024.02.008. Epub 2024 Mar 15.
10
Structures revealing mechanisms of resistance and collateral sensitivity of Plasmodium falciparum to proteasome inhibitors.揭示疟原虫对蛋白酶体抑制剂的耐药性和副作用敏感性机制的结构。
Nat Commun. 2023 Dec 14;14(1):8302. doi: 10.1038/s41467-023-44077-2.